Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lachno, D. Richard
24  Ergebnisse:
Personensuche X
?
1

Derivation of cutoffs for the Elecsys® amyloid β (1–42) ass..:

Shaw, Leslie M. ; Waligorska, Teresa ; Fields, Leona...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.  10 (2018)  1 - p. 698-705 , 2018
Link: https://doi.org/10.1016/..
 
?
2

Central pharmacodynamic activity of solanezumab in mild Alz..:

Willis, Brian A. ; Sundell, Karen ; Lachno, D. Richard...
Alzheimer's & Dementia: Translational Research & Clinical Interventions.  4 (2018)  1 - p. 652-660 , 2018
Link: https://doi.org/10.1016/..
 
?
3

A digital enzyme-linked immunosorbent assay for ultrasensit..:

Song, Linan ; Lachno, D. Richard ; Hanlon, David...
Alzheimer's Research & Therapy.  8 (2016)  1 - p. , 2016
Link: https://doi.org/10.1186/..
 
?
4

A phase 1 study of prasugrel in patients with sickle cell d..:

Jakubowski, Joseph A. ; Zhou, Chunmei ; Jurcevic, Stipo...
Thrombosis Research.  133 (2014)  2 - p. 190-195 , 2014
Link: https://doi.org/10.1016/..
 
?
5

P4‐076: INCLUSION OF PATIENTS WITH ALZHEIMER'S DISEASE PATH..:

Dean, Robert ; Shaw, Leslie M. ; Waligorska, Teresa W....
Alzheimer's & Dementia.  10 (2014)  4S_Part_22 - p. , 2014
Link: https://doi.org/10.1016/..
 
?
6

CSF biomarker variability in the Alzheimer's Association qu..:

Mattsson, Niklas ; Andreasson, Ulf ; Persson, Staffan...
Alzheimer's & Dementia.  9 (2013)  3 - p. 251-261 , 2013
Link: https://doi.org/10.1016/..
 
?
7

P1–342: Effects of solanezumab versus placebo administratio..:

Dean, Robert ; Siemers, Eric ; Carlson, Christopher...
Alzheimer's & Dementia.  9 (2013)  4S_Part_7 - p. , 2013
Link: https://doi.org/10.1016/..
 
?
8

A phase 1 study of prasugrel in patients with sickle cell d..:

Jakubowski, Joseph A. ; Zhou, Chunmei ; Small, David S....
British Journal of Clinical Pharmacology.  75 (2013)  6 - p. 1433-1444 , 2013
Link: https://doi.org/10.1111/..
 
?
9

Pharmacodynamics and pharmacokinetics of single doses of pr..:

Small, David S. ; Payne, Christopher D. ; Kothare, Prajakti...
Clinical Therapeutics.  32 (2010)  2 - p. 365-379 , 2010
Link: https://doi.org/10.1016/..
 
?
10

Changes of Urine Dihydroxyphenylglycol to Norepinephrine Ra..:

Montoya, Alonso ; Escobar, Rodrigo ; García-Polavieja, María J....
Journal of Child Neurology.  26 (2010)  1 - p. 31-36 , 2010
Link: https://doi.org/10.1177/..
 
?
11

The pharmacokinetics and pharmacodynamics of prasugrel in h..:

Small, David S. ; Kothare, Prajakti ; Yuen, Eunice...
European Journal of Clinical Pharmacology.  66 (2009)  2 - p. 127-135 , 2009
Link: https://doi.org/10.1007/..
 
?
12

O3‐04‐05: ELISA‐based measurement of plasma total Aβ1‐40 an..:

Dean, Robert A. ; DeMattos, Ronald ; Gelfanova, Valentina...
Alzheimer's & Dementia.  5 (2009)  4S_Part_5 - p. , 2009
Link: https://doi.org/10.1016/..
 
?
13

P‐057: Validation of the xMAP technology and performance of..:

Shaw, Leslie M. ; Vanderstichele, Hugo ; Knapik-Czajka, Margaret...
Alzheimer's & Dementia.  3 (2007)  3S_Part_1 - p. , 2007
Link: https://doi.org/10.1016/..
 
?
14

[P4–155]: DERIVING A CUT‐OFF FOR THE ELECSYS® β‐AMYLOID (1–..:

Shaw, Leslie M. ; Waligorska, Teresa ; Fields, Leona...
Alzheimer's & Dementia.  13 (2017)  7S_Part_27 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
15

[P2–002]: EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGEN..:

Schwarz, Adam J. ; Sundell, Karen L. ; Lachno, David Richard...
Alzheimer's & Dementia.  13 (2017)  7S_Part_12 - p. , 2017
Link: https://doi.org/10.1016/..
 
1-15